PLENARY SESSION
TUESDAY, AUGUST 19, 2025
11:30 am Introduction on GINA and the Current Landscape
Jessica Lynn Roberts, JD, Professor of Law, Artificial Intelligence, Machine Learning and Data Science, Emory Law
11:40 am PLENARY PANEL DISCUSSION: Genetic Discrimination: Impact of Genetic Test Results on Access to Life, Long-Term Care, and Disability Insurance
PANEL MODERATOR:
Laura Geller, National Investigative Producer, CBS
Genetic testing has become progressively more important in predicting disease risk and has facilitated the development of targeted therapies. Passed in 2008, the Genetic Information Nondiscrimination Act (GINA) prohibits genetic discrimination by health plans and employers. However, this federal law does not apply to life, long-term care, or disability insurers so it is legal to use genetic test results in these coverage or premium decisions.
PANELISTS:
Jennifer R. Leib, Founder, Innovation Policy Solutions LLC
John William Musick, Patient Advocate, End the Legacy
Lisa Schlager, Vice President, Public Policy, FORCE Facing Our Risk of Cancer Empowered
12:15 pm Keynote Panel Introduction (Opportunity Available)
12:20 pm PLENARY PANEL DISCUSSION: From AI to LDTs: Top Lab Advocacy Topics
PANEL MODERATOR:
Susan Van Meter, President, American Clinical Laboratory Association
- Reimbursement issues to be covered will include improving coding policy for new and existing codes, bringing rationality to Medicare payment through PAMA reform, and cutting through aggressive payer prior-authorization practices and other barriers to care and payment
- Regulatory issues will delve into the latest for LDTs from the administration, courts, and Congress
PANELISTS:
Jonathan R. Genzen, PhD, CMO, ARUP Labs
Lauren R. Silvis, PhD, Senior Vice President, External Affairs, Tempus, Inc.
Rachel Stauffer, Principal, McDermottPlus Consulting LLC
1:05 pm Session Break
1:10 pm Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own